The European Medicines Agency (EMA) has recommended the approval of additional production lines at the plant Pfizer vaccines in the city of Poor, Belgium.
This recommendation from Coreper “is expected to have a significant and direct impact on the supply of ‘Comirnaty’, the COVID-19 vaccine developed by BioNTech and Pfizer, to the EU”, the European Medicines Agency said in a statement.
Based on a review of data submitted by BioNTech Manufacturing GmbH, the EMA decision confirms that the plant in Pours is capable of consistently producing high quality vaccines and allows Pfizer / BioNTech to increase the volume of vaccines produced in this unit. production.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
